HIDRA + valproic acid

HIDRA + valproic acid is a combination drug consisting of two components. Valproic acid is a well-established anticonvulsant and mood stabilizer used primarily for the treatment of epilepsy (various seizure types), bipolar disorder (manic episodes), and migraine prophylaxis. Its mechanism involves increasing gamma-aminobutyric acid (GABA) levels in the brain, inhibiting voltage-gated sodium channels, modulating histone deacetylase activity, and affecting multiple molecular targets related to neuronal excitability and gene expression[2][3][5]. The identity of "HIDRA" as a pharmaceutical ingredient or brand could not be confirmed from available sources; therefore, its pharmacological properties remain unclear. This combination may be under investigation or used off-label in certain contexts.